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Hirudin is a thrombin-specific inhibitor of ikfr 8000 (65 amino acid residues). Native hirudin contains 3 
disulfide linkages within the first 39 amino-terminal residues, and a highly acidic C-terminal segment which 
is freely accessible to enzyme digestion by both endo- and exo-peptidases. Removal of the acidic C-terminal 
amino acids of native hirudin by both chemical and enzymatic methods resulted in a concomitant loss of 
hirudin inhibition activity. It is concluded that this acidic C-terminal segment of hirudin is essential for 
hirudin-thrombin interaction. The implication of the hirudin-thrombin interaction for the enzymatic 
specificity of thrombin is also discussed. 
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1. INTRODUCTION 
Hirudin is a thrombin-specific inhibitor and is 
the most potent thrombin inhibitor known [l-3]. 
It binds to a-thrombin (with Ki of 6.3 x 10-l’ M 
as compared to 10e6 M of fibrinogen) and inac- 
tivates the enzyme irreversibly. This exceedingly 
high binding affinity, together with the observa- 
tion that diisopropylphosphoryl-thrombin binds to 
hirudin with virtually the same Ki as native throm- 
bin [1,3,4] has led to the speculation that interac- 
tion of hirudin and thrombin must comprise multi- 
ple binding sites [3-51. 
two prolines. Those distinct features imply that the 
domain structure of native hirudin may play an im- 
portant role in the hirudin-thrombin interaction. 
We attempt here to characterize the functional role 
of the acidic C-terminal domain of native hirudin. 
2. MATERIALS AND METHODS 
2.1. Materials 
The structure of hirudin [2] has some unique 
features (fig.1). (a) There are 3 disulfide linkages 
located within the first 39 N-terminal residues of 
native hirudin. (b) Hirudin contains a highly acidic 
C-terminal segment. There are 5 acidic amino 
acids, 4 Glu and one Tyr-SOjH, within the last 9 
C-terminal residues. (c) One of the likely reactive 
sites of hirudin comprises a Lys residue flanked by 
Hirudin was isolated from leech and was kindly 
provided by Dr U. Seemtiller (University of 
Munich). The purity of hirudin was ascertained by 
SDS-gel electrophoresis and by quantitative N- 
terminal analysis [6]. DABITC and DABS-Cl were 
obtained from Fluka. Trypsin (TPCK treated) and 
carboxypeptidase Y were purchased from Wor- 
thington. Staphylococcal protease V8 was obtain- 
ed from Miles. Bovine thrombin and the substrate 
Tos-Gly-Pro-Arg-pNA were obtained from 
Boehringer. 
Note: Thrombin refers to cY-thrombin unless otherwise 2.2. Methods used in protein structure 
indicated determination 
Abbreviations: DABITC, dimethylaminoazobenzene 
isothiocyanate; DABS-Cl, dimethylaminoazobenzene- 
sulfonyl chloride 
N-terminal amino acids of polypeptides were 
quantitatively analysed by the DABITC method 
[6]. Amino acid compositions of polypeptides were 
determined by the DABS-Cl precolumn derivatiza- 
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Fig. 1. The primary structure of hirudin. Arrows indicate the Glu-X bonds of native hirudin cleaved by staphylococcal 
protease after 1 h digestion (also, see footnote to table 1). Cleavage positions were determined by 4 steps of automatic 
Edman degradation [25] and percentages of cleavage were based on the recovery of N-terminal Val as 100%. The 
sequence is taken from [2] and the precise sequence between residues 50-55 has not been established. 
tion method [7,8]. C-terminal sequencing was per- 
formed by combination of the carboxypeptidase Y 
digestion [9] and DABS-Cl methods [7,8]. 
2.3. Determination of the inhibition activity of 
native hirudin and modified hirudins 
The activities of native hirudin and modified 
hirudins were measured by their ability to inhibit 
thrombin from releasing colored p-nitroaniline 
from the chromogenic substrate Tos-Gly-Pro-Arg- 
pNA. Twenty microliters of thrombin solution 
(5 IU/ml, in 0.25 M phosphate, pH 6.5) was 
diluted with 890 ~1 triethanolamine buffer 
(0.1 ml/l, pH 8.4) and mixed with 5 ng hirudin (in 
50 ~1 triethanolamine buffer). The mixture was in- 
cubated at 25°C for 5 min, then added with 125 ,& 
Tos-Gly-Pro-Arg-pNA solution (1.5 mM). The 
molar ratio of hirudin : thrombin was 1 : 2. The in- 
crease of absorbancy was monitored at 405 nm 
within a 5 min period. 
3. RESULTS 
3.1. The acidic C-terminal segment of native 
hirudin is accessible to enzyme digestion by 
both endo- and exo-peptidases 
Although its 3-dimensional structure is not 
known, the unique primary structure of hirudin [2] 
provides clues for one to suggest that native 
hirudin may contain an N-terminal compact do- 
main (held by 3 disulfide linkages) and a C- 
terminal hydrophilic (acidic) domain which is ex- 
posed on the surface of the hirudin molecule. This 
two-domain model is supported by the following 
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Fig.2. Release of C-terminal amino acids of native 
hirudin by carboxypeptidase Y digestion (solid curves). 
One nmol native hirudin was digested with 1 pg 
carboxypeptidase Y in 50~1 acetate buffer (pH 5.4) at 
room temperature. Aliquots (10 ~1) were removed at 
time intervals (3, 10, 20 and 40 min), freeze-dried and 
derivatized with DABS-Cl. Five percent of each 
derivatized sample (10 pmol) was applied for HPLC 
analysis according to the method described in fig.3. The 
yield of Tyr-SOsH (Y*) was corrected for 12% 
desulfated derivative. The Glu curve represents only 
50% of the Glu yield. The release rates of Leu and Phe 
(dashed line) from a reduced carboxymethylated hirudin 
were selected for comparison. The release rates of C- 
terminal amino acids fit correctly to the reported hirudin 
sequence. 
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experiments. (a) Native hirudin is not digested by 
aminopeptidase M, which indicates that the N- 
terminal amino acid is buried within the N- 
terminal compact domain. (b) The C-terminal 
amino acids of native hirudin were released by car- 
boxypeptidase Y at a rate which is comparable to 
that of reduced carboxymethylated hirudin (fig.2), 
clear evidence that the C-terminal segment of 
native hirudin must be freely accessible to enzyme 
digestion on the surface of the molecule. (c) When 
native hirudin was digested by staphylococci pro- 
tease [lo] (an enzyme that specifically cleaves 
Giu-X bonds), cleavage only occurred at Glu-X 
bonds located in the C-terminal region (fig.1). 
There was no detectable cleavage with the three 
Glu-X bonds which are located within the N- 
terminal compact domain. (d) While oxidized and 
reduced carboxymethylated hirudins were readily 
digested by trypsin at Lys-Cys and Lys-Asn 
bonds (both located within the N-terminal com- 
u 10 20 ;uI 
TIME CMIN> 
Fig.3. Structure characterization f C-terminal modified hirudins by analysis of amino acids released from hirudin after 
carboxypeptidase Y digestion, (a) 200 pmol native hi~din were digested with 0.2& ~boxy~ptidase Y at room 
temperature for 20 min. The sample was freeze-dried and derivatized with DABS-Cl, and 5% of the sample (10 pmol) 
was injected for amino acid analysis. (b) 200 pmol native hirudin were incubated with 20 pl of 30% trifmoroacetic acid 
at 70°C for 15 min, freeze-dried and then processed as described in(a). The arrows indicate the conversion of Tyr-SOSH 
to Tyr (desulfation) after acid treatment. DABS-amino acids are symbolized by the one-letter code of their 
corresponding amino acids. The appearance of Giy was not expected from the sequence of hirudin and is likely to be 
a contamin~t. Chromatographical onditions were: solvent A, 12 mM phosphate (PH 6.5); solvent B, acetonitrile 
containing 4% dimethylformamide. Gradient, 12-37% B/O-22 min, 37-60% B/22-35 min, kept at 60% B from 
35-40 min, then 60-12% B/40-45 min. Column, Merck Lichrosorb RP-18 (5 pm). Column temperature, 50°C. 
Detector, 436 nm, 0.01 absorbance full scale. 
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pact domain), native hirudin was not accessible to 
trypsin digestion at all. It is clear that both 
Lys-Cys and Lys-Asn bonds were digested by 
trypsin only when the 3 disulfide linkages were 
disrupted. The other trypsin-susceptible site, 
Lys-Pro located near the C-terminal domain. 
However, it is known that Lys-Pro is not readily 
digested by trypsin. 
3.2. Removal of the C-terminal acidic amino acids 
of native hirudin resulted in a concomitant 
loss of hirudin inhibition activity 
Three types of hirudins modified at the C- 
terminal region were prepared in order to 
characterize the functional role of the acidic C- 
terminal domain. (a) Hirudin with the Tyr-SO3H 
at position 63 desulfated. (b) Hirudin with the last 
7 C-terminal amino acids deleted by carboxypep- 
tidase Y digestion. (c) Hirudin with the last 22 C- 
terminal amino acids deleted by staphylococcal 
protease digestion. The structures of the desulfated 
and carboxypeptidase Y digested hirudins were 
determined by amino acids analysis (fig.3). The 
structures of the staphylococcal protease digested 
hirudins were determined by automatic Edman 
degradation (fig.1). Table 1 summarizes the struc- 
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tures and surviving activities of those modified 
hirudins. 
In preparing the enzymatically modified 
hirudins, an unorthodox approach has been 
adopted due to the scarcity of hirudin. For in- 
stance, both carboxypeptidase Y and staphylococ- 
cal protease modified hirudins were assayed in the 
presence of those enzymes and the released amino 
acids or peptides. However, control experiments 
were carried out to show that both carboxypep- 
tidase Y and staphylococcal protease do not ex- 
hibit any inhibition activity under the conditions 
described (table 1). From table 1, several conclu- 
sions can be drawn. (a) The native hirudin used in 
this study was only 88% sulfated at residue 63. (b) 
Desulfation of native hirudin was accompanied by 
a linear decrease of hirudin inhibition activity and 
the Tyr-SO3H residue probably accounts for less 
than 30% of the total hirudin inhibition activity. It 
is, however, arguable that denaturation of native 
hirudin caused by acid treatment may also account 
for the loss of inhibition activities. (c) Removal of 
the last 7 C-terminal amino acids (including two 
Glu and one Tyr-SO3H) from native hirudin 
resulted in a loss of at least 90% of the hirudin in- 
hibition activity. (d) Removal of the last 22 C- 
K - q G q F I A q G G G F--k-/1 
v - G G q F L A q G G G iV R/G: 
Q -aGmF I ABG G GjV R/G; 
Fig.4. The structure similarity of hirudin C-terminal segment and fibrinopeptides A (FPA), fibrinopeptides B (FPB). 
Acidic amino acids, Asp (D), Glu (E) and Tyr-SOSH (Y*) are boxed. The sequence of hirudin is aligned from the C- 
terminal direction toward the N-terminal direction. 
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Table 1 
The structure and surviving activity of modified hirudin 
Treatment of hirudin” Structurea Survivingb 
activity (olo) 
Native hirudin 12% desulfated 100 
30% Trifluoroacetic acid, 5O”C, 25 min 46% desulfated 89 
30% Trifluoroacetic acid, 60°C 15 min 60% desulfated 87 
30% Trifluoroacetic acid, 7O”C, 15 min 93% desulfated 73 
30% Trifluoroacetic acid, 8O”C, 15 min 100% desulfated 45 
Carboxypeptidase Y, 20 min At least 95% of hirudin with the last 5 C-terminal 
amino acids removed, see fig.2 8 
Carboxypeptidase Y, 40 min See fig.2 7 
Staphylococcal protease, 20 min Not determined 42 
Staphylococcal protease, 1 h 45% of the C-terminal 22 amino acids deleted 27 
Staphylococcal protease, 2 h 74% of the C-terminal 22 amino acids deleted 16 
Staphylococcal protease, 4 h Not determined 3 
a Three types of modified hirudin were prepared. (a) Four samples of 1.5 nmol native hirudin were incubated with 20 gl 
of 30% aqueous trifluoroacetic acid under varied conditions. The samples were freeze-dried, redissolved in 30~1 
water. One-third of the sample (0.5 nmol) was removed for C-terminal analysis (see fig.3) to determine the extent of 
desulfation. The remaining samples were used for bioassay. (b) Two samples of native hirudin (1.5 nmol each) were 
digested with 1.5 pg carboxypeptidase Y in 30 ~1 acetate buffer (pH 5.4) at room temperature for 20 and 40 min. Ten 
~1 (0.5 nmol) of each sample was removed for the analysis of the released C-terminal amino acids and the remaining 
samples were freeze-dried and used for bioassay. A blank sample (with only 1.5 pg carboxypeptidase Y) was carried 
out for control experiment. (c) Four samples of 2 nmol each of native hirudin were incubated with 2 ,ug staphylococcal 
protease in 40 pl of 0.1 M ammonium bicarbonate (pH 8.0) at 37°C for 20 min, 1 h, 2 h and 4 h. Fifty percent of 
each sample was removed for 4 step N-terminal sequencing to determine the cleaving point and the remaining samples 
were used for bioassay. A blank sample (containing only 2 pg staphylococcal protease) was carried out as a control 
experiment 
b The inhibition activity of native hirudin (12% desulfated) was taken as 100% 
terminal amino acids causes nearly quantitative 
abolishment of hirudin inhibition activity. 
The above results clearly indicate that the acidic 
C-terminal segment of hirudin is essential for 
hirudin activity. However, efficient binding of 
hirudin to thrombin requires the intactness of the 
hirudin molecule, as reduced carboxymethylated 
and oxidized hirudins [2], or fragmented C- 
terminal segments of hirudin do not exhibit ap- 
preciable inhibition activities (less than 3% of the 
native one). 
4. DISCUSSION 
u-Thrombin has been classified as a ‘weak serine 
proteinase’ with a preferential arginine specificity 
[4,5,11]. It is also known that the high-affinity 
protein-binding or recognition site which is in- 
dependent of its catalytic site accounts for the high 
enzymatic specificity of thrombin toward protein 
substrate [4,5]. However, the nature of this 
recognition site has not yet been unequivocally 
defined. 
The acidic C-terminal segment of hirudin, in ad- 
dition to its demonstrated function of interacting 
with thrombin, displays an intriguing structural 
similarity to both fibrinopeptides A and 
fibrinopeptides B (fig.4) [ 121. They all have similar 
length and they are all very acidic. One post- 
translationally modified amino acid, Tyr-SOsH, 
which was found in hirudin is also present in the 
fibrinopeptides B of a large number of species [131. 
If one aligns the last 20 C-terminal amino acids of 
hirudin (from the C-terminal toward the N- 
terminal direction) with fibrinopeptides A and B, 
the homology becomes more evident. There are 
clusters of acidic amino acids located at regions 
about 9-17 amino acids apart from the thrombin 
311 
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active site binding regions. The most interesting 
feature of the hirudin C-terminal segment is 
perhaps the region which aligns with the thrombin 
cleaving points of fibrinogen & and B/3 chains. 
While h and B,& chains possess Val-Arg-Gly and 
Ala-Arg-Gly structures, the potential reactive site 
of hirudin has a unique structure of Pro-Lys-Pro. 
The preceding proline serves to enhance the affini- 
ty of the hirudin reactive site to the active site of 
thrombin [3,5], and the succeeding proline presides 
to resist the cleavage of the hirudin reactive site by 
the active site of thrombin. 
Although there is no precedent for comparing 
the amino acid sequence from reversed directions, 
this intriguing sequence homology (fig.4) at least 
raises the plausibility that thrombin may recognize 
its substrate through those homologous acidic 
regions. There exists in thrombin a basic recogni- 
tion site which is independent of but adjacent o its 
catalytic site and is comprised of clusters of Arg 
and Lys. With large protein substrates, only those 
Arg-X (or Lys-X) bonds which have acidic 
regions at approximate distances apart from the 
cleavage site can be more effectively recognized 
and cleaved by thrombin. In the hirudin-thrombin 
complex, the acidic C-terminal segment of hirudin 
binds to the recognition site of thrombin, while 
Pro-Lys-Pro fits into the active site of thrombin. 
This proposed mechanism is well supported by 
mounting documented evidence. (a) In the B-chain 
of a-thrombin, there exists a highly conserved 
Arg/Lys cluster [3 1. Cleavage at this basic segment 
converts highly clotting Q-thrombin to fl- and y- 
thrombins [ 14,151. Hirudin complexing with a- 
thrombin prevents enzymatic conversion to ,& and 
y-thrombins [3]. This implies that hirudin binding 
masks the basic recognition site which is responsi- 
ble for the high clotting activity (or high protein 
binding affinity) of a-thrombin. (b) Acetylated 
thrombin [4,16] lost most of its clotting activity 
whereas it retained substantial esterase activity. 
Nor does acetylated thrombin bind to hirudin. It is 
likely that acetylation blocks the lysine f-groups 
which are located in the recognition site of throm- 
bin. (c) Kinetic studies [17] on the varied size of 
synthetic h peptides have shown that the Asp 
residue at the Pro position of fibrinopeptide A 
plays an important role in the fibrinopeptide 
A-thrombin interaction. (d) Though thrombin is a 
serine proteinase [4], it is not inhibited by pro- 
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teinase inhibitors of plant origin [3] or by pan- 
creatic inhibitors which inhibit trypsin and 
plasmin. On the other hand, hirudin is only throm- 
bin specific [ 1,2] and it does not inhibit trypsin or 
plasmin. All these facts suggest hat thrombin and 
hirudin must interact via a unique structure that is 
independent of the active site of serine proteinase. 
(e) Most well characterized thrombin-susceptible 
Arg-X bonds [5,18] are about 8-15 amino acids 
apart from an acidic amino acid region. The 
significant difference of thrombin cleavage rates 
between human and ovine growth hormones [ 191 is 
probably due to the higher acidity and more op- 
timal distance of the acidic region presented in 
ovine growth hormone: 
Human growth hormone [20,21] 
GIE_TLMGRLEGSPRR” T 
(residues 120- 135) 
Ovine growth hormone [22] 
~GALMR~L~VTPRR” A 
(residues 119- 134) 
(f) In several genetically abnormal fibrinogens, the 
C-terminal Arg of fibrinopeptide A is replaced by 
His. This His-Gly bond has been reported to be 
cleaved by thrombin [23,24]. This occurrence is 
likely due to the strong interaction of the acidic 
fibrinopeptide A with the recognition site of 
thrombin which brings the relatively weak basic 
side chain of His into the Arg binding pocket and 
thus results in His-Gly cleavage. 
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